Citation data

CrossRef

Works that cite this article, indexed by Crossref.

49 resultsUpdated October 25, 2026
1

Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection

Arab Journal of Gastroenterology 24(1) (2023)

Merve Sefa Sayar; Dilek Bulut; Ali Acar

2

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

BMC Genomics 19(1) (2018)

Jie Liu; Yue Xiao; Xikun Wu; Lichun Jiang; Shurong Yang; Zhiming Ding; Zhuo Fang; Haiqing Hua; Mark Stephen Kirby; Jianyong Shou

3

Is Aspartate Aminotransferase to Platelet Ratio Index a Better Noninvasive Score for Predicting Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Patients?

Euroasian journal of hepato-gastroenterology 14(1) (2024)

Priyansh D Bhayani; Sarojini A Parameswaran; Kallippatti R Palaniswamy; Paramasivan Piramanayagam; Natarajan Murugan

4

Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

Expert Review of Proteomics 17(7-8) (2020)

Paweł Małecki; Joanna Tracz; Magdalena Łuczak; Magdalena Figlerowicz; Katarzyna Mazur-Melewska; Wojciech Służewski; Anna Mania

5

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Cureus (2021)

Bandana Kumari; Ramesh Kumar; Sadhana Sharma; Ayan Banerjee; Visesh Kumar; Pawan Kumar; Neha Chaudhary; Sushil Kumar; Khushboo Raj

6

Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Volume 14 (2021)

Muhammad Shah Alam; ABM Kamrul-Hasan; Syeda Tanzina Kalam; SM Mizanur Rahman; Mohammad Izazul Hoque; Md. Belalul Islam; Ajit Kumar Paul

8

Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans

Journal of Viral Hepatitis 27(10) (2020)

Martin Tibuakuu; Caroline Jjingo; Gregory Dale Kirk; David Lee Thomas; Ronald Gray; Victor Ssempijja; Fred Nalugoda; David Serwadda; Ponsiano Ocama; Christopher Kenneth Opio; David Erwin Kleiner; Thomas Charles Quinn; Steven James Reynolds

9

The Association of Fibrosis-4 (FIB 4) index with Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients with Concomitant Non-Alcoholic Fatty Liver Disease: A Single Center Cross-sectional Study

Philippine Journal of Internal Medicine 63(2) (2025)

Antonio O Pescador; Gabriel V Jasul; Oliver Allan C Dampil; Juliet L Gopez-Cervantes; Luz Margaret A Escueta

10

Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

Cureus (2022)

Bandana Kumari; Sadhana Sharma; Ramesh Kumar; Satish Dipankar; Bijaya N Naik; Ayan Banerjee; Sushil Kumar

11

The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy

Clinical and Experimental Nephrology 28(11) (2024)

Hailang Wei; Bingqing Liao; Qi Zhou; Xuhua Zhou; Yue Zhong; Yanbin Hao; Fuhua Xie; Runxiu Wang

12

Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease

Marine Drugs 20(6) (2022)

Jiayao Feng; Yongjian Liu; Jiajia Chen; Yan Bai; Jincan He; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su

13

Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study

BMC Gastroenterology 26(1) (2026)

Hossein Bagheri; Niloofar Seighali; Mohammad Sadra Gholami-Chahkand; Mahmood Bakhtiyari; Fateme Seighali; Fatemeh Jodeiri; Mohsen Rajabnia

14

Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms

Laboratory Medicine Online 13(3) (2023)

Min-Kyeong Kim; Heon-Ju Kwon; Kangsu Shin; Hyosoon Park; Hee-Yeon Woo; Chang-Hun Park; Min-Jung Kwon

15

FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH

Liver International 44(12) (2024)

Laura Martínez‐Arenas; Carmen Vinaixa; Isabel Conde; Sara Lorente; Fernando Díaz‐Fontenla; Patrice Marques; Judith Pérez‐Rojas; Eva Montalvá; Ângela Carvalho‐Gomes; Marina Berenguer

16

Phase angle as a severity indicator for liver diseases

Nutrition 70 (2020)

Ana Paula Pagano; Juliana Maria Faccioli Sicchieri; Isabela Laurencio Schiavoni; Daniel Barbeiro; Camila Sanches Manca; Bruna Ramos da Silva; Amanda Escobar Bezerra; Lívia Cristina Mendonça Pinto; Roberta Chaves Araújo; Andreza Correa Teixeira; Paula Garcia Chiarello

17

Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study

Korean Journal of Radiology 18(6) (2017)

Shuangshuang Xie; Qing Li; Yue Cheng; Yu Zhang; Zhizheng Zhuo; Guiming Zhao; Wen Shen

21

Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases 33(9) (2023)

Kálmán Bódis; Maria Bombrich; Martin Schön; Birgit Knebel; Oana-Patricia Zaharia; Gidon Bönhof; Yanislava Karusheva; Klaus Strassburger; Yuliya Kupriyanova; Jörg Kotzka; Rainer Guthoff; Vera Schrauwen-Hinderling; Hadi Al-Hasani; Volker Burkart; Julia Szendroedi; Robert Wagner; Daniel F. Markgraf; Michael Roden

22

Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats

Chinese Medicine 16(1) (2021)

Yu Xiong; Jinyuan Hu; Chen Xuan; Jiayu Tian; Kaiyue Tan; Zhiwei Chen; Yan Luo; Xuqin Du; Junxiong Cheng; Lanyue Zhang; Wenfu Cao

23

Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis

World Journal of Hepatology 14(4) (2022)

Layal Al Nadaf; Mohammed Hussein Kamareddine; Emilie Fayad; Aniqa Hussain; Said Farhat

26

Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers

Contemporary Clinical Trials 97 (2020)

Stephen A. Harrison; Salvatore Calanna; Kenneth Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun Sanyal; Anne-Sophie Sejling; Philip N. Newsome

27

Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease

BMC Gastroenterology 25(1) (2025)

Hanaa Badran; Maha Elsabaawy; Mai Magdy; Hazem Omar; Olfat Hendy; Eman Awaad; Maymona Abd El-Wahed Al-Khalifa; Mai Abozeid

28

Clinical utility of non-invasive markers in the assessment of liver fibrosis among type 2 diabetes mellitus patients

Turkish Journal of Biochemistry 51(4) (2026)

Thilak Priyantha Weerarathna; Keddagoda Gamage Piyumi Wasana; Iroshani Kodikara; Suneth Ruwan Weerarathna

29

Diagnostic Accuracy of Red Cell Distribution Width to Platelet Ratio for the Prediction of Liver Fibrosis in Patients With Chronic Liver Disease From Eastern India

Cureus (2025)

D Pavan Sai Kumar Rao; Shubhransu Patro; Vibha Sharma; Arushi Choudhary; Shubham Desale; Preetam Nath

30

A clinical case of non-alcoholic fatty liver disease with polycystic ovary syndrome

Terapevt (General Physician)(7) (2025)

L.A. Dudareva; A.V. Tkachev; A.M. Aslanov; G.N. Tarasova; V.A. Kosenko; K.E. Mazovka; E.N. Veselova; L.S. Mkrtchyan; L.V. Sudyina; Yu.Yu. Chebotareva

31

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease

Diagnostics 12(4) (2022)

Anca Trifan; Adrian Rotaru; Remus Stafie; Ermina Stratina; Sebastian Zenovia; Robert Nastasa; Laura Huiban; Tudor Cuciureanu; Cristina Muzîca; Stefan Chiriac; Irina Gîrleanu; Ana-Maria Sîngeap; Catalin Sfarti; Camelia Cojocariu; Carol Stanciu

32

FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning

Medicine 102(34) (2023)

Yuping Ding; Zuoyu Wang; Haiyan Niu; Quanjun Deng; Yanan Wang; Shihai Xia

33

High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

Scientific Reports 11(1) (2021)

Haruka Saito; Hayato Tanabe; Akihiro Kudo; Noritaka Machii; Moritake Higa; Satoshi Yamaguchi; Gulinu Maimaituxun; Kazumichi Abe; Atsushi Takahashi; Kenichi Tanaka; Koichi Asahi; Hiroaki Masuzaki; Hiromasa Ohira; Junichiro J. Kazama; Michio Shimabukuro

34

Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population

Exploration of Endocrine and Metabolic Diseases 2 (2025)

Jianmin Tang; Halengbieke Aheyeerke; Chao Tong; Xuetong Ni; Tengrui Cao; Yumei Han; Shuo Chen; Linrun Kong; Xinghua Yang

35

The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients

Journal of Clinical Gastroenterology 52(3) (2018)

Amandeep Singh; Phuc Le; Maajid M. Peerzada; Rocio Lopez; Naim Alkhouri

36

Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients

Diabetes, Metabolic Syndrome and Obesity Volume 17 (2024)

Yuping Ding; Guiqiang Wang; Quanjun Deng; Mei Yang; Jinghua Li; Zuoyu Wang; Haiyan Niu; Shihai Xia

37

Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study

International Journal of Molecular Sciences 22(18) (2021)

Ana J. F. C. Aguiar; Jaluza L. C. de Queiroz; Pedro P. A. Santos; Christina S. Camillo; Alexandre C. Serquiz; Izael S. Costa; Gerciane S. Oliveira; Ana F. T. Gomes; Lídia L. R. Matias; Rafael O. A. Costa; Thaís S. Passos; Ana H. A. Morais

38

Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease

Biomedicines 12(11) (2024)

Joana D’Arc Matos França de Abreu; Rossana Sousa Azulay; Vandilson Rodrigues; Sterffeson Lamare Lucena de Abreu; Maria da Glória Tavares; Flávia Coelho Mohana Pinheiro; Clariano Pires de Oliveira Neto; Caio Andrade; Alexandre Facundo; Adriana Guimarães Sá; Patrícia Ribeiro Azevedo; Ana Gregória Pereira de Almeida; Debora Camelo de Abreu Costa; Rogério Soares Castro; Marcelo Magalhães; Gilvan Cortês Nascimento; Manuel dos Santos Faria; Adalgisa de Souza Paiva Ferreira

39

Creatinine-to-body weight ratio as a marker of metabolic dysfunction and obesity-related steatosis in Egyptian patients

Egyptian Liver Journal 16(1) (2026)

Shimaa Ebrahim; Ebtesam Shady; Shimaa Mansour

40

Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis

Journal of Ethnopharmacology 264 (2021)

Yuan Zhou; Rong Wu; Fei-Fei Cai; Wen-Jun Zhou; Yi-Yu Lu; Hui Zhang; Qi-Long Chen; Shi-Bing Su

43

Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

Journal of Clinical Medicine 13(21) (2024)

Iván Ferraz-Amaro; Alejandro Hernández-Camba; Marta Carrillo-Palau; Noemi Hernández Álvarez-Buylla; Antonia de Vera-González; Alejandra González-Delgado; Elena Heras-Recuero; Miguel Á. González-Gay

44

The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease

International Heart Journal 60(5) (2019)

Tetsuro Yokokawa; Koichi Sugimoto; Akiomi Yoshihisa; Takuya Goto; Tomofumi Misaka; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi

46

Platelet Proteomics: A Glimpse Into Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

Hepatology Research 56(4) (2026)

Iulia Minciuna; Maria Iacobescu; Ioana Rusu; Oana Nicoara‐Farcau; Petra Fischer; Andreea Maria Soporan; Ioana Ecaterina Pralea; Horia Stefanescu; Cristina Adela Iuga; Bogdan Procopet

47

Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway

Biomedicine & Pharmacotherapy 128 (2020)

Manman Chen; Jingwei Xing; Danqing Pan; Xiuhua Peng; Pengfei Gao

48

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease

Egyptian Liver Journal 10(1) (2020)

Ahmed M. F. Mansour; Essam M. Bayoumy; Ahmed M. ElGhandour; Mohamed Darwish El-Talkawy; Sameh M. Badr; Ahmed El-Metwally Ahmed